About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,806 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,806 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1361-1380 of 10,806 trials

CompletedEvaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) InfectionThis is a clinical sampling study, and no study drugs will be administered under this protocol.NCT01602614·Birmingham, Alabama and 14 others Active not recruitingPhase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple MyelomaThe purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant in an effort to help prolong…NCT02253316·Duarte, California and 9 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedStudy of BHV-3241 in Participants With Multiple System AtrophyThe purpose of this study is to compare the efficacy of verdiperstat (BHV-3241) versus placebo in participants with Multiple System AtrophyNCT03952806·Phoenix, Arizona and 47 others

CompletedSecondary Prevention of Small Subcortical Strokes TrialThe goal of this study is to learn if combination antiplatelet therapy (aspirin and clopidogrel) is more effective than aspirin alone for the prevention of recurrent stroke and…NCT00059306·Mobile, Alabama and 62 others

RecruitingCephea Early Feasibility StudyThe objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve…NCT05061004·Phoenix, Arizona and 21 others

UnknownA Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic CancerThe main objective for part 1a of the study is to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) and to evaluate the safety, tolerability…NCT05076552·Orange, California and 7 others

WithdrawnA Open Label Extension Study for Subjects That Complete Study MP-101-CL-001MP-101 will be evaluated in this study to see if it is safe and tolerable.NCT02246816·Chicago, Illinois and 4 others

TerminatedA Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept in participants with treatment-naïve DME.NCT04611152·La Jolla, California and 74 others

CompletedStudy Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung CancerThe main purpose of this first study combining an investigational dual mTOR inhibitor, CC-223, with other agents (erlotinib or the investigational agent, oral azacitidine) is to…NCT01545947·Los Angeles, California and 8 others

CompletedA Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric CataractTo assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery…NCT04539548·Aurora, Colorado and 13 others

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 125 others

CompletedEffects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsThis is a Phase I study to test the safety, pharmacokinetics and effectiveness of STM 434 alone, or in combination with liposomal doxorubicin, in patients with ovarian cancer or…NCT02262455·Boston, Massachusetts and 3 others

RecruitingThe HOPE Biobank Resource (BMT CTN 2402 HOPE)A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene…NCT07227155·Duarte, California and 13 others

TerminatedStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)This study is an open-label Phase 1/2 evaluation of CB-839 in combination with nivolumab in participants with clear cell renal cell carcinoma, melanoma, and non-small cell lung…NCT02771626·Scottsdale, Arizona and 16 others

CompletedA Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or…NCT03283085·Mesa, Arizona and 418 others

TerminatedA Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerThis study is a multi-institution, Phase Ia/Ib/IIa open-label, dose-finding, safety, pharmacokinetics (PK), and proof-of-concept study of GDC-0810 as a single agent and in…NCT01823835·San Diego, California and 13 others

CompletedThe Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With OnychomycosisThe purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.NCT01007708·Hot Springs, Arkansas and 43 others

CompletedRadiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue SarcomaRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor.NCT00023725·Birmingham, Alabama and 225 others

CompletedBiospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma SurvivorsThis research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors.NCT03206450·Birmingham, Alabama and 98 others

CompletedInactivated Influenza A/H5N1 Vaccine in the ElderlyThe purpose of this research study is to compare how the body reacts to different strengths of a new H5N1 flu vaccine.NCT00230750·Torrance, California and 3 others

PreviousPage 69 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville